ANALYST REPORT

Ubisoft's stock is in the spotlight again. Barclays' Nick Dempsey has kept his Hold rating on the company, setting a price target of €6. 40. This news comes after a recent report from Dempsey, who is known for his decent track record in the Communication Services sector. Dempsey isn't the only one

Investors are keeping a close eye on healthcare stocks, especially Pfizer and Oneview Healthcare. Both companies have been under the microscope lately, with analysts sharing their thoughts on where these stocks might be headed. Pfizer, a big name in the pharmaceutical world, has seen some mixed rev